N-Terminal Natriuretic Peptide and Ventilation-Perfusion Lung Scan in Sickle Cell Disease and Thalassemia Patients with Pulmonary Hypertension

REFERENCES

• Borgna-Pignatti C, Rugolotto S, De Stefano P, Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89(10):1187–1193.
   PubMed Web of Science ®Google Scholar
• Castro O, Gladwin MT. Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management. Hematol Oncol Clin North Am. 2005;19(5):881–896.
   PubMedGoogle Scholar
• Vichinsky EP. Pulmonary hypertension in sickle cell disease. N Engl J Med 2004;350(9):857–859.
   PubMed Web of Science ®Google Scholar
• Borgna-Pignatti C, Carnelli V, Caruso V, Thromboembolic events in β thalassemia major: an Italian multicenter study. Acta Haematol. 1998;99(2):76–79.
   PubMedGoogle Scholar
• Liem RI, Young LT, Thompson AA. Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension. Haematologica. 2007;92(11):1549–1552.
   PubMed Web of Science ®Google Scholar
• Worsley DF, Palevsky HI, Alavi A. Ventilation-perfusion lung scanning in the evaluation of pulmonary hypertension. J Nucl Med. 1994;35(5):793–796.
   PubMedGoogle Scholar
• Tunariu N, Gibbs SJ, Win Z, Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med. 2007;48(5):680–684.
   PubMed Web of Science ®Google Scholar
• Lubien E, DeMaria A, Krishnaswamy P, Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation. 2002;105(5):595–601. (Erratum in: Circulation. 2002;106(3):387.)
   PubMed Web of Science ®Google Scholar
• Machado RF, Anthi A, Steinberg MH, N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA 2006;296(3):310–318.
   PubMedGoogle Scholar
• Cappellini MD, Cohen A, Eleftheriou A, Piga A, Porter J, Taher A, Eds. Thalassemia intermedia and Hb E. Guidelines for The Clinical Management of Thalassemia, 2nd ed. Nicosia: Thalassemia International Federation. 2008;11:121–131.
   Google Scholar
• Worsley DF, Alavi A. Comprehensive analysis of the results of the PIOPED study. Prospective investigation of pulmonary embolism diagnosis study. J Nucl Med. 1995;36(12):2380–2387.
   PubMedGoogle Scholar
• Pashankar FD, Carbonella J, Bazzy-Asaad A, Friedman A. Prevalence and risk factors of elevated pulmonary artery pressure in children with sickle cell disease. Pediatrics. 2008;121(4):777–782.
   PubMedGoogle Scholar
• Vicari P, de Cassia Rosario Cavalheiro R, de Gouveia A, Filho Campos O, Figueiredo MS. Echocardiographic abnormalities in Brazilian sickle cell patients. Am J Hematol. 2005;78(2):160–161.
   PubMedGoogle Scholar
• Manci EA, Culberson DE, Yang YM, Investigators of the Cooperative Study of Sickle Cell Disease. Causes of death in sickle cell disease: an autopsy study. Br J Haematol. 2003;123(2):359–365.
   PubMed Web of Science ®Google Scholar
• Atichartakarn V, Likittanasombat K, Chuncharunee S, Pulmonary arterial hypertension in previously splenectomized patients with β-thalassemic disorders. Int J Hematol. 2003;78(2):139–145.
   PubMed Web of Science ®Google Scholar
• Tam DH, Farber HW. Pulmonary hypertension and β-thalassemia major: report of a case, its treatment, and a review of the literature. Am J Hematol. 2006;81(6):443–447.
   PubMedGoogle Scholar
• Du ZD, Roguin N, Milgram E, Saab K, Koren A. Pulmonary hypertension in patients with thalassemia major. Am Heart J. 1997;134:532–537.
   PubMed Web of Science ®Google Scholar
• Kato GJ, McGowan V, Machado RF, Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood. 2006;107(6):2279–2285.
   PubMed Web of Science ®Google Scholar
• Morris CR, Kato GJ, Poljakovic M, Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA. 2005;294(1):81–90.
   PubMed Web of Science ®Google Scholar
• Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293(13):1653–1662.
   PubMed Web of Science ®Google Scholar
• Aessopos A, Farmakis D, Loukopoulos D. Elastic tissue abnormalities resembling pseudoxanthoma elasticum in β-thalassemia and the sickling syndrome. Blood. 2002;99(1):30–35.
   PubMed Web of Science ®Google Scholar
• Aessopos A, Farmakis D, Loukopoulos D. Elastic tissue abnormalities in inherited haemolytic syndromes. Eur J Clin Invest. 2002;32(9):640–642.
   PubMed Web of Science ®Google Scholar
• Kremastimes DT, Tsetsos GA, Tsiapras DP, Karavolias GK, Ladis VA, Kallamis CA. Heart failure in β-thalassemia: a 5 year follow up study. Am J Med. 2001;111:349–34.
   PubMedGoogle Scholar
• Voskaridou E, Tsetsos G, Tsoutsias A, Spyropoulou E, Christoulas D, Terpos E. Pulmonary hypertension in patients with sickle/β thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations. Haematologica. 2007;92(6):738–743.
   PubMedGoogle Scholar
• Wu KH, Chang JS, Su BH, Peng CT. Tricuspid regurgitation in patients with β-thalassemia major. Ann Hematol. 2004;83(12):779–783.
   PubMedGoogle Scholar
• Aessopos A, Farmakis D. Pulmonary hypertension in β-thalassemia. Ann NY Acad Sci. 2005;1054:342–349.
   PubMed Web of Science ®Google Scholar
• Ohga S, Ideguchi H, Kato J, Thromboembolic complications in splenectomized patients with dominantly inherited β-thalassemia. Acta Haematol. 2008;120(1):31–35.
   PubMed Web of Science ®Google Scholar
• Phrommintikul A, Sukonthasarn A, Kanjanavanit R, Nawarawong W. Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia. Heart. 2006;92(10):1467–1472.
   PubMed Web of Science ®Google Scholar
• Kato GJ, Hsieh M, Machado R, Cerebrovascular disease associated with sickle cell pulmonary hypertension. Am J Hematol. 2006;81(7):503–510.
   PubMed Web of Science ®Google Scholar
• Ohene-Frempong K, Weiner SJ, Sleeper LA, Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91(1):288–294.
   PubMed Web of Science ®Google Scholar
• Onyekwere OC, Campbell A, Teshome M, Pulmonary hypertension in children and adolescents with sickle cell disease. Pediatr Cardiol. 2008;29(2):309–312.
   PubMed Web of Science ®Google Scholar
• Souza R, Jardim C, Julio Cesar Femandes C, Sliveira Lapa M, Rabelo R, Humbert M. NT-pro-BNP as a tool to stratify disease severity in pulmonary arterial hypertension. Respir Med. 2007;101(1):69–75.
   PubMed Web of Science ®Google Scholar
• Bernus A, Wagner BD, Accurso F, Doran A, Kaess H, Ivy DD. Brain natriuritic peptide levels in managing pediatric patients with pulmonary arterial hypertension. Chest. 2009;135(3):745–751.
   PubMedGoogle Scholar
• Gladwin MT, Sachdev V, Jison ML, Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350(9):886–895.
   PubMed Web of Science ®Google Scholar
• Fedullo PF, Auger WR, Kerr KM, Kim NH. Chronic thromboembolic pulmonary hypertension. Semin Respir Crit Care Med. 2003;24(3):273–286.
   PubMedGoogle Scholar
• Lisbona R, Derbekyan V, Novales-Diaz J. Scintigraphic evidence of pulmonary vascular occlusion in sickle cell disease. J Nucl Med. 1997;38(7):1151–1153.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya M, Kannan M, Chaudhry VP, Mahapatra M, Pati H, Saxena R. Hypercoagulable state in five thalassemia intermedia patients. Clin Appl Thromb Hemost. 2007;13(4):422–427.
   PubMed Web of Science ®Google Scholar
• Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood. 2002;99(1):36–43.
   PubMed Web of Science ®Google Scholar
• Kaur N, Motwani B, Sivasubramaniam D, Potential role of the ventilation and perfusion (V/Q) lung scan in the diagnosis of acute chest syndrome in adults with sickle cell disease. Am J Hematol. 2004;77(4):407–409.
   PubMedGoogle Scholar
• Walker BK, Ballas SK, Burka ER. The diagnosis of pulmonary thromboembolism in sickle cell disease. Am J Hematol. 1979;7(3):219–232.
   PubMedGoogle Scholar
• Anthi A, Machado RF, Jison ML, Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am J Respir Crit Care Med. 2007;175(12):1272–1279.
   PubMed Web of Science ®Google Scholar